SATURNUS AG has a total of 21 patent applications. Its first patent ever was published in 1993. It filed its patents most often in EPO (European Patent Office), Australia and United States. Its main competitors in its focus markets pharmaceuticals, medical technology and audio-visual technology are WANG HONGKUI, GILROSE PHARMACEUTICALS LLC and HUZHOU CHINESE MEDICINE HOSPITAL.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | Australia | 4 | |
#3 | United States | 4 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Belgium | 1 | |
#6 | Canada | 1 | |
#7 | China | 1 | |
#8 | Finland | 1 | |
#9 | Hungary | 1 | |
#10 | Netherlands | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Audio-visual technology | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Diagnosis and surgery | |
#4 | Syringes | |
#5 | Measuring distances | |
#6 | Television | |
#7 | Implantable devices |
# | Name | Total Patents |
---|---|---|
#1 | Koninckx Philippe Robert Marie | 9 |
#2 | Koninckx Robert Philippe | 4 |
#3 | Koninckx Robert | 4 |
#4 | Koninckx P R M W G | 1 |
Publication | Filing date | Title |
---|---|---|
AU1848899A | Preparation for substitution therapy, containing at least one progestogen and at least one estrogen | |
EP0887076A2 | Adhesion prevention and an endoscopic insufflation system therefor | |
BE1010290A3 | TISSUE-morcellator. | |
HU9600592D0 | The use of progestogen and estrogen for manufacturing a pharmaceutical composition for substitution therapy and oral contraception | |
CA2171460A1 | Preparation for substitution therapy, containing at least one progestogen and at least one extrogen | |
AU6991794A | Tv camera with rotational orientation correction |